首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1729415

日本醫藥第三方物流市場報告（按服務、溫度控制和地區）2025-2033

Japan Pharmaceutical 3PL Market Report by Service, Temperature Control, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本醫藥第三方物流市場規模達 59 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 152 億美元，2025-2033 年期間的成長率 (CAGR) 為 10.26%。製藥公司越來越關注其核心競爭力，如藥物開發和研究，而不受分銷和合規複雜要求的束縛，這主要推動了市場的成長。

醫藥產業的第三方物流（3PL）在最佳化藥品製造商和分銷商的供應鏈方面發揮關鍵作用。製藥第三方物流供應商提供專業的物流服務，確保藥品依照嚴格的監管標準進行儲存、處理和運輸，確保其功效和安全性。鑑於藥品的關鍵性及其對病人健康的直接影響，此物流框架內對精確性、及時性和合規性有著內在的需求。如今，隨著製藥業努力應對全球化市場、不斷成長的需求和複雜的監管環境，這些第三方物流供應商在應對這些挑戰方面發揮著重要作用。透過整合先進技術、即時追蹤和合規管理，醫藥第三方物流在製造商和最終用戶之間架起了無縫橋樑，確保救命藥物及時、以最佳狀態到達目的地。

日本醫藥第三方物流市場趨勢：

日本醫藥第三方物流市場以國家醫療保健供應鏈為特徵，體現了效率、精確度和合規性。主要促進因素之一是藥品領域複雜的監管環境。由於對儲存、運輸和分銷有嚴格的規定，許多製藥公司選擇將這些物流挑戰外包給具備專業知識和基礎設施的第三方物流供應商。技術融合是塑造市場的另一個趨勢。物聯網設備、人工智慧分析和區塊鏈的興起確保了整個藥品供應鏈的即時監控、增強的安全性和透明的可追溯性。這不僅提高了效率，而且還最大限度地降低了假冒或違反合規性的風險。此外，由於日本地理環境複雜，且需要最後一哩的配送解決方案，特別是針對老化的農村人口，第三方物流供應商正在不斷創新，以確保藥品能夠到達最偏遠的地區。最後，持續的全球健康挑戰凸顯了強大而靈活的供應鏈的重要性。疫情引發的混亂使得製藥公司更加依賴第三方物流合作夥伴來應對不確定性並確保供應的連續性。本質上，監管需求、技術進步、人口挑戰和健康狀況的結合預計將推動日本醫藥第三方物流市場在預測期內實現顯著成長。

日本醫藥第三方物流市場區隔：

服務洞察：

國內運輸管理
國際運輸管理
加值倉儲和配送

溫度控制見解：

受控/冷鏈物流
非受控/非冷鏈物流

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。一些關鍵參與者包括：

DHL
聯邦快遞公司
嘉里物流聯網有限公司（順豐速運有限公司）
德迅
日本通運株式會社
鈴研株式會社

本報告回答的關鍵問題：

日本醫藥第三方物流市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本醫藥第三方物流市場有何影響？
日本醫藥第三方物流市場如何依服務分類？
根據溫度控制，日本醫藥第三方物流市場是如何分類的？
日本醫藥第三方物流市場的價值鏈分為哪些階段？
日本醫藥第三方物流的關鍵促進因素與挑戰是什麼？
日本醫藥第三方物流市場的結構是怎麼樣的？主要參與者有哪些？
日本醫藥第三方物流市場的競爭程度如何？

本報告回答的關鍵問題：

日本醫藥第三方物流市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本醫藥第三方物流市場有何影響？
日本醫藥第三方物流市場如何依服務分類？
根據溫度控制，日本醫藥第三方物流市場是如何分類的？
日本醫藥第三方物流市場的價值鏈分為哪些階段？
日本醫藥第三方物流的關鍵促進因素與挑戰是什麼？
日本醫藥第三方物流市場的結構是怎麼樣的？主要參與者有哪些？
日本醫藥第三方物流市場的競爭程度如何？

Japan pharmaceutical 3PL market size reached USD 5.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.2 Billion by 2033, exhibiting a growth rate (CAGR) of 10.26% during 2025-2033. The increasing focus of pharmaceutical companies on their core competencies, like drug development and research, without being encumbered by the intricate demands of distribution and compliance, is primarily driving the market growth.

Third-party logistics (3PL) in the pharmaceuticals sector plays a pivotal role in optimizing the supply chain for drug manufacturers and distributors. Pharmaceutical 3PL providers offer specialized logistics services, ensuring that medications are stored, handled, and transported under stringent regulatory standards, guaranteeing their efficacy and safety. Given the critical nature of pharmaceuticals and their direct impact on patient health, there's an inherent need for precision, timeliness, and compliance within this logistical framework. Today, as the pharmaceutical industry grapples with a globalized market, rising demand, and complex regulatory environments, these 3PL providers become instrumental in navigating these challenges. By integrating advanced technologies, real-time tracking, and compliance management, pharmaceutical 3PLs offer a seamless bridge between manufacturers and end-users, ensuring that lifesaving medications reach their destinations promptly and in optimal condition.

Japan Pharmaceutical 3PL Market Trends:

The Japan pharmaceutical 3PL market is characterized by the nation's healthcare supply chain, epitomizing efficiency, precision, and compliance. One of the primary drivers is the complex regulatory environment surrounding pharmaceuticals. With stringent guidelines on storage, transportation, and distribution, many pharma companies are opting to outsource these logistics challenges to 3PL providers equipped with specialized knowledge and infrastructure. Technological integration is another trend shaping the market. The rise of IoT devices, AI-driven analytics, and blockchain ensures real-time monitoring, enhanced security, and transparent traceability throughout the drug supply chain. This not only improves efficiency but also minimizes the risk of counterfeits or compliance breaches. Furthermore, with Japan's geographical intricacies and the need for last-mile delivery solutions, especially to its aging rural population, 3PL providers are innovating to ensure that medications reach even the most remote areas. Lastly, the ongoing global health challenges have underscored the importance of a robust and agile supply chain. The pandemic-induced disruptions have made pharmaceutical companies more reliant on 3PL partners to navigate uncertainties and ensure continuity of supply. In essence, the combination of regulatory demands, technological advancements, demographic challenges, and health scenarios are projected to propel the Japan pharmaceutical 3PL market for significant growth over the forecasted period.

Japan Pharmaceutical 3PL Market Segmentation:

Service Insights:

Domestic Transportation Management
International Transportation Management
Value-added Warehousing and Distribution

Temperature Control Insights:

Controlled/Cold Chain Logistics
Non-controlled/Non-Cold Chain Logistics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

DHL
FedEx Corporation
Kerry Logistics Network Limited (SF Express Co. Ltd.)
Kuehne + Nagel
Nippon Express Co. Ltd.
Suzuken Co. Ltd.

Key Questions Answered in This Report:

How has the Japan pharmaceutical 3PL market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan pharmaceutical 3PL market?
What is the breakup of the Japan pharmaceutical 3PL market on the basis of service?
What is the breakup of the Japan pharmaceutical 3PL market on the basis of temperature control?
What are the various stages in the value chain of the Japan pharmaceutical 3PL market?
What are the key driving factors and challenges in the Japan pharmaceutical 3PL?
What is the structure of the Japan pharmaceutical 3PL market and who are the key players?
What is the degree of competition in the Japan pharmaceutical 3PL market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmaceutical 3PL Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Pharmaceutical 3PL Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Pharmaceutical 3PL Market - Breakup by Service

6.1 Domestic Transportation Management
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 International Transportation Management
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Value-added Warehousing and Distribution
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Pharmaceutical 3PL Market - Breakup by Temperature Control

7.1 Controlled/Cold Chain Logistics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Non-controlled/Non-Cold Chain Logistics
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Pharmaceutical 3PL Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 DHL
- 9.1.1 Business Overview
- 9.1.2 Services Offered
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 FedEx Corporation
- 9.2.1 Business Overview
- 9.2.2 Services Offered
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Kerry Logistics Network Limited (SF Express Co. Ltd.)
- 9.3.1 Business Overview
- 9.3.2 Services Offered
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Kuehne + Nagel
- 9.4.1 Business Overview
- 9.4.2 Services Offered
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events
9.5 Nippon Express Co. Ltd.
- 9.5.1 Business Overview
- 9.5.2 Services Offered
- 9.5.3 Business Strategies
- 9.5.4 SWOT Analysis
- 9.5.5 Major News and Events
9.6 Suzuken Co. Ltd.
- 9.6.1 Business Overview
- 9.6.2 Services Offered
- 9.6.3 Business Strategies
- 9.6.4 SWOT Analysis
- 9.6.5 Major News and Events

10 Japan Pharmaceutical 3PL Market - Industry Analysis

10.1 Drivers, Restraints and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis